News

VIDEO: Longer period of postpartum thromboembolic risk raises therapeutic questions


 

Findings from a large study of women following their first pregnancy extend the postpartum period of heightened risk for thromboembolic events from the previously known 6 weeks to 12 weeks, leaving physicians with new questions that need to be answered in further studies about the need for longer periods of anticoagulation therapy in some women. In a video interview, Dr. Bruce Ovbiagele of the Medical University of South Carolina, Charleston, comments on the findings at the International Stroke Conference. The study also was published Feb. 13 in the New England Journal of Medicine in conjunction with the report at the conference (2014 Feb. 13 [doi:10.1056/NEJMoa1311485).

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

West Nile virus has cost the United States nearly $800 million
MDedge Internal Medicine
NSAID makers argue against new warnings on CV risks
MDedge Internal Medicine
Obesity at age 20 associated with increased risk of multiple sclerosis
MDedge Internal Medicine
No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge Internal Medicine
Pregabalin improves restless leg syndrome with less symptom augmentation
MDedge Internal Medicine
Video: Positive trends for outcomes in uric acid stroke trial gives optimism
MDedge Internal Medicine
Video: Study hints uric acid reduces acute stroke symptoms
MDedge Internal Medicine
Uric acid for stroke trials to continue
MDedge Internal Medicine
VIDEO: Postpartum elevated thrombosis risk lasts 12 weeks
MDedge Internal Medicine
Postpartum thrombosis risk high for 12 weeks
MDedge Internal Medicine

Related Articles